Bicester Expansion for UK Electric Vehicle Company Arrival
UK electric van maker Arrival Ltd has further expanded at Link 9 Bicester, which completes the final letting at the major new industrial scheme.
Oxford Nanopore partners with UK Gov on new generation COVID-19 test
The test is fully scalable and designed to enable both high-volume screening and rapid, local testing, and results can be obtained in under two hours.
£24m Investment in New Bicester Development
Aver Property Partnership is spending over £24 million on the development of a new distribution and manufacturing park at Bicester, Oxfordshire.
Abingdon Business Park secures healthcare company at Blacklands Way
Royal London Asset Management has successfully completed the final letting of its Blacklands Way development at Abingdon Business Park in Oxfordshire.
Oxford-based The Native Antigen Company acquired by LGC
The Native Antigen Company, leading suppliers of high-quality infectious disease antigens and antibodies, has announced its acquisition by LGC.
New Bellhouse Building completed at The Oxford Science Park
The 30,000 sq ft Bellhouse Building is named after academic entrepreneur Professor Brian Bellhouse, and the first tenants are expected to move in by end of summer.
Tinbergen building replacement virtual public consultation
A public consultation event is scheduled for June 2020, and the University will be submitting a planning application to Oxford City Council by June 2020.
Electric vehicle company further expands manufacturing base
Electric van maker Arrival Ltd has taken on another new property at Network @ Link 9 in Bicester as it continues its rapid expansion.
Oxford Nanopore announces £48.4M in new capital to support ongoing innovation
Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital from new investors and existing shareholders in EMEA, US and Asia.
UK Space Agency launches drive to strengthen NHS coronavirus response
The UK Space Agency launches a new drive to fund space-enabled technology and services that can strengthen the NHS response to coronavirus.